Rhesus Macaque Breeding Program 2019

Award Date 6/20/2019
Last Date To Order 6/19/2024
Shared Ceiling $17M
Contract Type
Master IDIQ
Successors

The Rhesus Macaque Breeding Program 2019 Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract is a specialized federal contract vehicle awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to support critical nonhuman primate (NHP) research infrastructure. The vehicle focuses on providing specific pathogen-free Indian-origin rhesus macaques for vaccine research, specifically targeting HIV/AIDS vaccine and prevention strategy development. With a total ceiling value of approximately $66 million, the contract enables the maintenance of breeding colonies and associated support services for scientific research purposes.

The Master IDIQ has awarded multiple delivery orders to prime contractors, including the University of Louisiana at Lafayette and Alpha Genesis Inc. Typical task orders range from $2.3 million to $10.7 million, with contract periods spanning approximately 5 years (June 2019 to June 2024). These contracts are not set-aside and are awarded as firm-fixed-price delivery orders, with contractors maintaining breeding colonies of 500-550 rhesus macaques in facilities located in states like Louisiana and South Carolina. The primary funding agency is NIAID, with a specific focus on supporting the Simian Vaccine Evaluation Units (SVEU) program. Contractors are responsible for animal husbandry, maintaining specific pathogen-free status, and providing NHPs for preclinical research in biosafety level 2 and 2/3 environments.

Generated 4/17/25, 3:41 AM